2019
DOI: 10.1016/j.biopha.2019.108662
|View full text |Cite
|
Sign up to set email alerts
|

MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
18
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 24 publications
(23 citation statements)
references
References 28 publications
5
18
0
Order By: Relevance
“…In the present study, we confirmed circCDR1as as a sponge of miR‐219a‐5p by dual‐luciferase reporter assay. Moreover, we found that miR‐219a‐5p expression declined in NSCLC and its overexpression repressed NSCLC development in vitro, which was also in agreement with previous studies . This indicated the anti‐cancer role of miR‐219a‐5p in NSCLC.…”
Section: Discussionsupporting
confidence: 92%
See 4 more Smart Citations
“…In the present study, we confirmed circCDR1as as a sponge of miR‐219a‐5p by dual‐luciferase reporter assay. Moreover, we found that miR‐219a‐5p expression declined in NSCLC and its overexpression repressed NSCLC development in vitro, which was also in agreement with previous studies . This indicated the anti‐cancer role of miR‐219a‐5p in NSCLC.…”
Section: Discussionsupporting
confidence: 92%
“…To further elucidate the ceRNA network in this study, the targets of miR‐219a‐5p were analyzed. Previous studies have confirmed multiple targets of miR‐219a‐5p in different conditions, such as high mobility group protein A2 (HMGA2), fibroblast growth factor 9 (FGF9) and eyes absent homolog 2 (EYA2) . In this study, we first confirmed the target association between miR‐219a‐5p and SOX5 in NSCLC cells.…”
Section: Discussionsupporting
confidence: 74%
See 3 more Smart Citations